Literature DB >> 32886179

Triptan overuse during pregnancy: a possible cause of placental hypoperfusion.

Delphine Viard1, Alexandre Gérard2, Jellila Tahiri3, Nathalie Tieulié4, Elise Van Obberghen2, Milou-Daniel Drici2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32886179     DOI： 10.1007/s00228-020-02991-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  12 in total

Review 1.  Mechanisms of action of the 5-HT1B/1D receptor agonists.

Authors:  Stewart J Tepper; Alan M Rapoport; Fred D Sheftell
Journal:  Arch Neurol       Date:  2002-07

2.  Tachyphylaxis to the sumatriptan-induced contractile effect in the human uterine artery but not in human cerebral blood vessels: pharmacological demonstration of the 5-HT(1B) receptor functionality loss.

Authors:  Sónia A Silva; Carlos A Fontes Ribeiro
Journal:  Pharmacology       Date:  2012-02-01       Impact factor: 2.547

3.  In utero analysis of fetal growth: a sonographic weight standard.

Authors:  F P Hadlock; R B Harrist; J Martinez-Poyer
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

4.  Pregnancy outcome after anti-migraine triptan use: A prospective observational cohort study.

Authors:  Kevin Spielmann; Angela Kayser; Evelin Beck; Reinhard Meister; Christof Schaefer
Journal:  Cephalalgia       Date:  2017-07-31       Impact factor: 6.292

5.  [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France].

Authors:  B Bégaud; J C Evreux; J Jouglard; G Lagier
Journal:  Therapie       Date:  1985 Mar-Apr       Impact factor: 2.070

6.  Triptan safety during pregnancy: a Norwegian population registry study.

Authors:  Kateřina Nezvalová-Henriksen; Olav Spigset; Hedvig Nordeng
Journal:  Eur J Epidemiol       Date:  2013-07-25       Impact factor: 8.082

7.  Fetal growth restriction and intra-uterine growth restriction: guidelines for clinical practice from the French College of Gynaecologists and Obstetricians.

Authors:  C Vayssière; L Sentilhes; A Ego; C Bernard; D Cambourieu; C Flamant; G Gascoin; A Gaudineau; G Grangé; V Houfflin-Debarge; B Langer; V Malan; P Marcorelles; J Nizard; F Perrotin; L Salomon; M-V Senat; A Serry; V Tessier; P Truffert; V Tsatsaris; C Arnaud; B Carbonne
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2015-07-02       Impact factor: 2.435

8.  Migraine with aura and reproductive life events: a case control study.

Authors:  F Granella; G Sances; E Pucci; R E Nappi; N Ghiotto; G Napp
Journal:  Cephalalgia       Date:  2000-10       Impact factor: 6.292

9.  Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.

Authors:  Giuseppe Roberto; Carlo Piccinni; Roberto D'Alessandro; Elisabetta Poluzzi
Journal:  Cephalalgia       Date:  2013-08-06       Impact factor: 6.292

Review 10.  Medication-overuse headache: a widely recognized entity amidst ongoing debate.

Authors:  Nicolas Vandenbussche; Domenico Laterza; Marco Lisicki; Joseph Lloyd; Chiara Lupi; Hannes Tischler; Kati Toom; Fenne Vandervorst; Simone Quintana; Koen Paemeleire; Zaza Katsarava
Journal:  J Headache Pain       Date:  2018-07-13       Impact factor: 7.277
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.